Promoters hold 75.0% of GlaxoSmithKline Pharmaceuticals Limited (GLAXO). FIIs hold 4.8%, mutual funds 4.9% and other DIIs 2.9%. No promoter pledge is reported. Quarterly shareholding, quarter ended Jun 26.
Folio counts aren't part of the shareholding pattern we ingest today — they arrive with a later filing parse.
| Holder | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 75.0% | 75.0% | 75.0% | 75.0% | 75.0% | 75.0% | 75.0% | 75.0% | 75.0% | 75.0% | 75.0% | 75.0% |
| FII | 4.8% | 4.6% | 4.6% | 4.8% | 4.9% | 4.5% | 4.5% | 4.4% | 4.0% | 3.5% | 2.9% | 2.5% |
| MF | 4.9% | 4.7% | 4.8% | 5.0% | 5.2% | 5.2% | 5.0% | 5.0% | 4.7% | 4.5% | 4.5% | 4.8% |
| Other DII | 2.9% | 3.0% | 2.9% | 2.7% | 2.5% | 2.6% | 2.3% | 2.4% | 2.8% | 3.4% | 4.1% | 5.2% |
| Retail & others | 12.4% | 12.7% | 12.7% | 12.4% | 12.4% | 12.7% | 13.2% | 13.3% | 13.5% | 13.6% | 13.4% | 12.5% |
No bulk or block deals disclosed for this stock in the last 90 days.
Bulk deals are uncommon for large caps — a single client has to trade over 0.5% of the company's shares in one day. Most weeks, none happen.
No PIT or SAST disclosures on record for this stock in the last 12 months.
That is the usual state — promoters, directors and holders above 5% file only when they trade or pledge; a new filing appears here within a day of reaching the exchange.
In Jun 26, FII holding rose +0.2pp and mutual funds +0.1pp, while retail trimmed −0.3pp. Rising institutional ownership is often read as “smart money” accumulation — though it’s never a guarantee.
Quarterly shareholding patternas of Jun 26
